Gene: WNT3
Official Full Name: Wnt family member 3provided by HGNC
Gene Summary: The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It encodes a protein which shows 98% amino acid identity to mouse Wnt3 protein, and 84% to human WNT3A protein, another WNT gene product. The mouse studies show the requirement of Wnt3 in primary axis formation in the mouse. Studies of the gene expression suggest that this gene may play a key role in some cases of human breast, rectal, lung, and gastric cancer through activation of the WNT-beta-catenin-TCF signaling pathway. This gene is clustered with WNT15, another family member, in the chromosome 17q21 region. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11625 | WNT3 Knockout cell line (HeLa) | Human | WNT3 | 1:3~1:6 | Negative | Online Inquiry |
KO11626 | WNT3 Knockout cell line (HCT 116) | Human | WNT3 | 1:2~1:4 | Negative | Online Inquiry |
KO11627 | WNT3 Knockout cell line (A549) | Human | WNT3 | 1:3~1:4 | Negative | Online Inquiry |
WNT3 Gene Knockout Cell Lines are specifically engineered cellular models that have undergone precise gene editing to disrupt the WNT3 gene, which encodes a critical protein involved in the WNT signaling pathway. This pathway plays a vital role in various biological processes, including cell proliferation, differentiation, and embryonic development. By knocking out the WNT3 gene, these cell lines provide researchers with an invaluable tool for studying the physiological and pathological roles of WNT signaling in a controlled environment.
The key mechanism of these knockout cell lines hinges on CRISPR-Cas9 technology, which allows for the specific targeting and inactivation of the WNT3 gene. This disruption elucidates the gene's functional contributions to various cellular behaviors, facilitating a deeper understanding of tumorigenesis, stem cell biology, and regenerative medicine. This product holds significant scientific importance as it enables researchers to dissect the complexities of the WNT pathway and its implications in diseases such as cancer, congenital disorders, and metabolic syndromes.
Compared to traditional methods that may involve transient gene silencing or overexpression models, WNT3 Gene Knockout Cell Lines offer stable, long-term gene disruption, allowing for more reproducible results. This stability makes these cell lines particularly advantageous for extensive drug screening and therapeutic assessments. Moreover, the specificity of the knockout helps minimize off-target effects, thus providing more reliable data.
This product is invaluable for researchers and clinicians who are focused on exploring new therapeutic avenues targeting WNT3's role in various disease states. Its application in high-throughput screening and pathway analysis can lead to groundbreaking discoveries and potential clinical interventions.
Our company prides itself on being at the forefront of gene editing technology and cell line development, ensuring high-quality, rigorously validated biological models to drive scientific innovation forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.